|
|
||||||||
ORIGINAL RESEARCH COMMUNICATION |
1 From the International Centre for Diarrhoeal Disease Research, Bangladesh (ICDDR,B): Centre for Health and Population Research, Dhaka, Bangladesh (SAS, HM, and GJF); the Laboratory for Human Nutrition, Institute of Food Science and Nutrition, Swiss Federal Institute of Technology, Zurich, Switzerland (LD, TW, and RFH); the Department of Internal Medicine, University of Basel, Switzerland (NG); and the Department of Pediatrics, University of Arkansas for Medical Sciences, Little Rock (GJF)
Background: Nonheme-iron absorption requires an acidic milieu. Reduced gastric acid output as a consequence of Helicobacter pylori infection could be an important limiting factor for iron absorption.
Objective: We measured gastric acid output and iron absorption from a non-water-soluble iron compound (ferrous fumarate) and a water-soluble iron compound (ferrous sulfate) in children with and without H. pylori infection.
Design: Gastric acid output was quantified before (basal acid output, or BAO) and after pentagastrin stimulation (stimulated acid output, or SAO) in 25-y-old children with iron deficiency anemia who were (n = 13) or were not (n = 12) infected with H. pylori. Iron absorption was measured by using a double-stable-isotope technique. H. pylori-infected children were studied before and after eradication therapy.
Results: BAO and SAO were significantly lower in the H. pylori-infected children (0.2 ± 0.2 and 1.6 ± 0.9 mmol/h, respectively) than in the uninfected children (0.9 ± 0.7 and 3.1 ± 0.9 mmol/h, respectively; P = 0.01 and P < 0.005). BAO and SAO improved to 0.8 ± 1.3 and 3.3 ± 2.4 mmol/h, respectively, after therapy. Iron absorption from ferrous sulfate was significantly greater than that from ferrous fumarate both before (geometric
: 19.7% compared with 5.3%; P < 0.0001) and after (22.5% compared with 6.4%; P < 0.0001) treatment in H. pylori-infected children. Corresponding values for uninfected children were 15.6% and 5.4%, respectively (P < 0.001; n = 12).
Conclusions: Iron absorption from ferrous fumarate was significantly lower than that from ferrous sulfate in both H. pylori-infected and uninfected Bangladeshi children. Treatment of H. pylori infection improved gastric acid output but did not significantly influence iron absorption. The efficacy of ferrous fumarate in iron fortification programs to prevent iron deficiency in young children should be evaluated.
Key Words: Helicobacter pylori gastric acid secretion iron absorption anemia ferrous fumarate iron status children
This article has been cited by other articles:
![]() |
A. D. Kaya, E. Gencay, C. E. Ozturk, and T. Yavuz Seroprevalence of Helicobacter pylori Infection in Children in Northwest Region of Turkey: Relationship with Iron Deficiency Anemia J Trop Pediatr, April 27, 2008; (2008) fmn028v1. [Full Text] [PDF] |
||||
![]() |
L. W. Tengco, P. Rayco-Solon, J. A. Solon, J. N. Sarol Jr., and F. S. Solon Determinants of Anemia among Preschool Children in the Philippines J. Am. Coll. Nutr., April 1, 2008; 27(2): 229 - 243. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Wijaya-Erhardt, J. G Erhardt, J. Untoro, E. Karyadi, L. Wibowo, and R. Gross Effect of daily or weekly multiple-micronutrient and iron foodlike tablets on body iron stores of Indonesian infants aged 6 12 mo: a double-blind, randomized, placebo-controlled trial Am. J. Clinical Nutrition, December 1, 2007; 86(6): 1680 - 1686. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. J. Windle, D. Kelleher, and J. E. Crabtree Childhood Helicobacter pylori Infection and Growth Impairment in Developing Countries: A Vicious Cycle? Pediatrics, March 1, 2007; 119(3): e754 - e759. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. B. Perez-Exposito, S. Villalpando, J. A. Rivera, I. J. Griffin, and S. A. Abrams Ferrous Sulfate Is More Bioavailable among Preschoolers than Other Forms of Iron in a Milk-Based Weaning Food Distributed by PROGRESA, a National Program in Mexico J. Nutr., January 1, 2005; 135(1): 64 - 69. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. A Abrams New approaches to iron fortification: role of bioavailability studies Am. J. Clinical Nutrition, November 1, 2004; 80(5): 1104 - 1105. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |